SAGE PRO

Home / Research / LIC Housing Finance

SAGE PRO · ORIGINAL EQUITY RESEARCH

LIC Housing Finance — Q2 FY27 Results Analysis

A mature mortgage lender whose investment case is earnings durability and credit normalization rather than rapid AUM growth.

Published · Quarter Q2 FY27 · LICHSGFIN

Reference price₹585.1
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

NII

Q2 FY26₹2,038 crore
Q2 FY27₹2,088 crore

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

CHART 2

PAT

Q2 FY26₹1,353.87 crore
Q2 FY27₹1,508.78 crore

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

CHART 3

NIM

FY262.62%
FY272.58%

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

CHART 4

Stage 3 EAD

FY262.51%
FY272.05%

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

A mature mortgage lender whose investment case is earnings durability and credit normalization rather than rapid AUM growth.

A narrow margin and competitive pricing can offset lower credit costs; project-finance growth requires renewed scrutiny.

Watch: Review the seven-chapter report and next-quarter tests.

RESEARCH INSIGHT

NII

Issuer-reported figures or explicitly labeled analyst calculations.

Watch: Compare against next-quarter results using consistent definitions.

RESEARCH INSIGHT

PAT

Issuer-reported figures or explicitly labeled analyst calculations.

Watch: Compare against next-quarter results using consistent definitions.

RESEARCH INSIGHT

NIM

Issuer-reported figures or explicitly labeled analyst calculations.

Watch: Compare against next-quarter results using consistent definitions.

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

16 November 2026 | Reference price ₹585.1 on 13 November 2026

Investment thesis: A mature mortgage lender whose investment case is earnings durability and credit normalization rather than rapid AUM growth.

1. Investment case

Key takeaways

  • LIC Housing Finance is a scale-and-credit-repair investment, not a high-growth housing finance compounder.
  • The September loan book is ₹326,173 crore, +5% YoY, while Q2 PAT increased 11% to ₹1,508.78 crore.
  • NIM slipped to 2.58% from 2.62%; NII increased only 2.5% to ₹2,088 crore.

This distinction is central: profit grew faster than spread income, so a valuation based on a permanently accelerating earnings trajectory requires evidence beyond the headline PAT. A mature HFC can create shareholder value through lower loss volatility, disciplined funding and modest capital consumption even at mid-single-digit book growth. Its risk is that competition from banks compresses yields faster than liability repricing, leaving a thin spread over a large long-duration asset base.

The reference share price ₹585.10 on 13 November must be assessed against current diluted shares and book value, not a stale March multiple. The issuer's FY26 historical chart shows EPS ₹101.72 and BVPS ₹751.24; if used as explicitly dated FY26 anchors they imply about 5.75x trailing FY26 EPS and 0.78x March book. These are not current September valuations. The apparent discount is a signal to investigate sustainable ROE, not automatic upside. [1]

2. Financial quality

MetricQ2 FY26Q2 FY27
Operating revenue ₹cr7,0747,175
NII ₹cr2,0382,088
PAT ₹cr1,353.871,508.78
NIM2.62%2.58%
Stage 3 EAD2.51%2.05%
ECL stock ₹cr5,0744,292

Key takeaways

  • Revenue grew 1.4%; NII grew 2.45%; PAT rose ₹154.91 crore.
  • The PAT increase is larger than the ₹50 crore NII improvement, which establishes the need for an operating expense, other-income, impairment and tax bridge.
  • Lower ECL stock is not the same as P&L impairment release.

The issuer's executive summary does not by itself establish the exact drivers; this report avoids assigning the residual profit increase to a specific credit reversal. FY22–FY26 loan portfolio CAGR 6%, profit CAGR 25% and disbursement CAGR 2% as presented: profitability recovery materially outpaced franchise growth. Repeating that PAT CAGR would require further returns improvement, not merely historical extrapolation. [1]

3. Origination and portfolio mix

Key takeaways

  • Retail portfolio ₹316,433 crore and project portfolio ₹9,740 crore.
  • Retail is 97.0% of the loan book.
  • Project loans grew 12%, faster than retail 4%; project disbursement ₹564 crore grew 49%, versus retail ₹17,563 crore +10%.

Total disbursements ₹18,127 crore versus ₹16,313 crore. Project finance is only 3% of the stock but can have larger loss severity and correlated developer exposures; growth should be measured against project stage, cash flows and collateral, not counted as interchangeable with individual mortgages. The scale of retail distribution and brand familiarity support customer acquisition.

Yet competitive prime mortgages have a high degree of price transparency, and borrowers may refinance when spreads widen. Disbursements annualized at current pace equal ~22% of the book before repayments, a scale illustration rather than projected growth. The difference between 11% disbursement growth and 5% loan growth makes retention and amortization critical. Track net additions, balance transfers and repricing by origination cohort. [1]

4. Credit and downside

Key takeaways

  • Stage 3 EAD declined 46 bps YoY to 2.05%, while total ECL stock fell ₹782 crore.
  • Improvement is meaningful, but the ECL stock includes Stages 1, 2 and 3 and cannot be equated with Stage 3 provision coverage.
  • An illustrative 50-bp annual credit-cost shock on the reported loan portfolio is ₹1,631 crore pretax, roughly 27% of annualized Q2 PAT before tax; actual exposure and impairment basis differ.

A 25-bp shock is ₹815 crore. With narrow NIM, small changes in losses can overwhelm incremental spread income. Project and retail credit must be tested separately. Require vintage-level overdue migration, individual versus developer cure/write-off flows, and collateral realization. A lower Stage 3 ratio during growth can also reflect denominator effects. The next meaningful evidence is the change in absolute impaired exposures and loss charges, not only ratios. [1]

5. Funding and capital economics

Key takeaways

  • The 2.58% NIM implies sensitivity to a relatively small asset-liability repricing mismatch.
  • A 10-bp annualized margin compression applied to the ₹326,173 crore loan portfolio is approximately ₹326 crore pretax; 25 bps ~₹815 crore.
  • This is a simplified sensitivity using the loan stock rather than actual average earning assets.

Long-duration mortgages funded by shorter or floating-rate instruments create reset and refinancing risk. Diversification through term loans, bonds, refinance and deposits must be evaluated against funding tenor and all-in cost. The historic AAA rating and LIC shareholding of 45.24% support franchise credibility but are not a government or parent guarantee. A low market P/B can persist when ROE is structurally below the cost of equity or the market doubts book-value quality. Analyze earnings retention, dividend, risk-weighted capital and funding maturities before treating discount to March book as realizable value. [1]

6. Valuation framework

Key takeaways

  • Annualized Q2 PAT ₹6,035 crore is the starting earnings capacity.
  • Bear assumes 15% lower earnings and 5x; base 6% growth and 7x; bull 15% growth and 9x.
  • These are illustrative equity value scenarios, not observed peers or formal price targets.

The historical FY26 EPS and BVPS anchors are explicitly dated, and September share-count/equity reconciliation remains necessary. The primary multiple driver is sustainable returns on a large low-yield asset book. Credit normalization can produce above-trend earnings but is finite; sustained upside requires steady NII growth, contained costs and credible capital return. Conversely a 20–25 bp spread shock combined with increased project losses could justify a persistent discount even with low reported P/E. The scenario grid should be updated with statutory EPS, current book and average assets.

CaseAnnualized normalized PAT ₹crMultipleEquity value ₹cr
Bear51305x25649
Base63977x44781
Bull69409x62463

Institutional deep dive — a low-multiple lender must earn its discount through cash returns

Scale, spread and profit quality. Q2 NII ₹2,088 crore versus ₹2,038 crore prior year, +₹50 crore; PAT +₹154.91 crore. The net profit change exceeds the entire NII increment. An investor must obtain the actual PPOP, other income, operating expense, impairment, tax and exceptional items bridge rather than attribute the difference to one factor.

The 2.58% NIM versus 2.62% prior year is a modest decline but meaningful on ₹326,173 crore loans. An annual 10bp movement on the closing book approximates ₹326 crore pre-tax. A one-quarter effect on a stable book is roughly ₹81.5 crore; actual average interest-earning assets and reset timing differ.

The Q2 NII increase can reflect volume offsetting yield pressure. The key thesis is not high current earnings growth but a sustainable spread and controlled loss across a vast asset base.

Illustrative gross annual stock sensitivity₹ crore before tax
10bp NIM compression326
25bp NIM compression815
25bp additional loss815
25bp margin + 25bp loss1,631

Combined stress is not a forecast: current PBT, asset and retained-risk denominator and actual liability/asset repricing are needed. Relative to annualized Q2 PAT ₹6,035 crore, combined gross pre-tax shock ~27% before tax. This illustrates how small changes in rate and loss can materially affect a mature lender's economic return. Low multiple is not protection against lower normalized earnings.

Loan growth and customer retention. Q2 disbursement ₹18,127 crore annualized ~₹72,508 crore, ~22.2% of current closing book. At 5% reported annual portfolio growth, implied prior-year book ~₹310,641 crore and net increase ~₹15,532 crore (using rounded growth).

Gross annualized current flow greatly exceeds that net growth; scheduled amortization and refinancing are structural. This is not a matched annual gross-to-net bridge because quarterly flow is annualized and period timing differs.

The analyst should reconstruct actual gross disbursed, principal collections, balance transfers out and new acquired/assigned portfolios. A stronger retail origination number can be offset by repayments if prime borrowers shift to banks at cheaper rates.

Retention pricing can preserve balances while reducing yield. Evaluate NII after attrition and net risk-adjusted spread, not disbursement alone.

Retail versus project: concentration matters more than a small mix percentage. Retail AUM ₹316,433 crore and project AUM ₹9,740 crore, ~97% and 3%. Project Q2 disbursement ₹564 crore (3.1% of total), +49% YoY.

Retail ₹17,563 crore +10%. A small project book can create disproportionate downside because construction risk is correlated, repayment is lumpy and exposures can be large. Illustrative 5% incremental loss on the closing project book is ₹487 crore pre-tax, ~8% of annualized Q2 PAT before tax.

This is not a prediction of developer losses; it demonstrates that a 3% portfolio mix is not a 3% share of possible stress. Underwrite project-by-project: completion milestones, escrow/cash flow, developer leverage, receivable collection, security, sales velocity and guarantees.

For retail, assess borrower affordability, loan-to-value, reset risk and recovery. Do not use the aggregate Stage 3 ratio for both.

Credit recovery and reserve economics. Stage 3 EAD 2.05% vs 2.51% prior year and ECL stock ₹4,292 crore vs ₹5,074 crore. As a rough closing portfolio proxy only, implied Stage 3 stock ~₹6,687 crore now versus ~₹7,798 crore using the inferred prior book ₹310,641 crore, a potential absolute reduction of ~₹1,111 crore.

EAD and portfolio denominators may differ; these are not statutory impaired balances. The result is more encouraging than a ratio-only improvement, but needs original stage movement to confirm. ECL decrease ₹782 crore can arise from recoveries, write-offs, disposals, stage migration or methodology changes.

It must not be booked as an assumed P&L release. The investor should compare new slippage, cash cures, write-offs and actual provision expense separately. Once credit repair normalizes, incremental profit growth will depend more on spread and efficient operating costs.

Funding and repricing. A large mortgage lender has longer-duration assets than many liability instruments. Its funding franchise and historic AAA rating can support competitive pricing, but the lender must manage actual reset dates, fixed/floating mix, wholesale concentration and refinancing.

A 25bp full-loan-stock spread sensitivity is distinct from a 25bp increase in borrowing rates: equity and cash/other funding affect the latter, and asset yields may reprice. Reconcile borrowing amount, contractual maturity, deposits and bond/term loan mix, then stress liability rollover and asset prepayment.

Brand/parent shareholding is not explicit repayment guarantee. The valuation should reflect normalized funding and capital rather than assume the lowest historical funding cost.

Dated-book valuation and economic profit. FY26 reported EPS ₹101.72 and BVPS ₹751.24 yield ~13.5% FY26 simple earnings/dating book proxy (EPS/closing book, not average ROE). The ₹585.10 reference price implies ~0.78x dated March book and ~5.75x dated FY26 earnings; September actual diluted shares and equity still require reconciliation.

If normalized ROE is 11%/14%/16%, cost of equity 15%/14%/13% and terminal growth 4%/5%/6%, justified steady-state P/B ~0.64x/1.00x/1.43x. These are clean-surplus terminal economics, not price targets; a low-growth business can still create value through dividends and reliable returns.

At a discount to dated book, downside is plausible if future returns fall below hurdle or asset losses reduce book. Upside requires credible capital return, low normalized losses and stable spread rather than an assumption that every lender trades above book.

Monitoring decision. Distinguish the next quarter's NII growth, PPOP growth and credit/tax effect on PAT. Require absolute Stage 3 and ECL stock/flow, actual net retail additions and project-level exposure; evaluate NIM changes against average funding and earning assets.

A stable NIM with mid-single-digit loan growth and durable low losses can justify the recovery case. If NII stagnates while earnings rise largely on reserve/tax effects, reduce the normalized growth assumption.

The original company-domain November 2 Q2 transcript has been located at the previous third-party-hosted transcript is not used. This upgrade relies on admitted original presentation and clearly labeled calculations; official transcript URL admission and statutory reconciliation remain open.

7. Catalysts and evidence limitations

Key takeaways

  • Monitor Stage 3 EAD below 2.05%, absolute impaired book, loan growth against 5%, retail disbursement conversion, project share, NIM around 2.58%, NII growth and credit charge.
  • A positive catalyst is sustained margin stabilization and PAT growth supported by operating earnings, not just reserve normalization.
  • A falsifier is continued NIM compression with project exposures growing faster than retail, or rising write-offs disguised by lower NPA ratio.

Compare FY27 earnings with FY26 historical figures rather than assuming the prior 25% PAT CAGR. Only original issuer Q2 presentation is admitted here. The stored call is a third-party-hosted file and is excluded by policy. Full statutory income bridge, September diluted share count, independently reconstructed ALM and current peer comparisons are open. This is available-source institutional research, not full-QA signoff. [1]

Original source ledger

[1] Q2 FY27 investor update (2026-10-30): original filing.

Key takeaways

  • Prices: Sage PRO canonical close, 13 November 2026.
  • All scenarios illustrative; no formal target or independently certified full QA.
  • Open items: Issuer deck only; original transcript, complete statutory bridge, current shares and ALM/peer reconciliation pending.

Q2 source and financial review · 18 November 2026

Key takeaways

  • The November 2 issuer call confirms a 25-bp increase in the benchmark lending rate effective October 31.
  • It is a post-quarter change.
  • Q2 NIM was 2.58%, flat sequentially and 4 bps below last year.

Pair the repricing with incremental borrowing costs and actual reset dates. The Q2 credit benefit also included recoveries, so retain a normalized provision charge in forward earnings.

Additional company evidence

CHART 5

Portfolio composition

Retail₹3,16,433 crore
Project₹9,740 crore

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

CHART 6

Disbursements

FY26₹16,313 crore
FY27₹18,127 crore

https://www.bseindia.com/xml-data/corpfiling/AttachLive/10f570e4-4500-49b6-9b26-4107cbf8effd.pdf

CHART 7

Illustrative equity value

Bear₹25,649 crore
Base₹44,781 crore
Bull₹62,463 crore

Analyst scenario

CHART 8

Profit bridge

NII increment₹50 crore
PAT increment₹154.91 crore

Analyst calculations from original Q2 source ledger

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Q2 FY27 investor update

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.